Nov. 18 Workshop on Unregulated Stem Cell Therapies
Although stem cell therapies hold tremendous potential for treating debilitating diseases such as Parkinson's disease and spinal cord injury, the evidence base to support the medical use of stem cells is still limited. Despite the preliminary nature of clinical evidence, clinics have been established throughout the world that offer "stem cell therapies" that are not being stringently regulated and have not been tested through rigorous trials to determine safety and likely benefit.
At this workshop of the Institute of Medicine and National Academy of Sciences, being held jointly with the International Society for Stem Cell Research, medical and legal experts will examine stem cell treatments that are available, the potential benefits and risks to individual health, the evidence base needed to substantiate the clinical application of stem cell technologies, and legal hurdles for establishing standards and criteria to govern stem cell trials and treatments. Participants will also discuss potential ways for assuring the quality of stem cell therapies.
DETAILS: The workshop will take place on Monday, Nov. 18, from 8:30 a.m. to 5:30 p.m. EST in Room 125 of the National Academy of Sciences building, 2101 Constitution Ave. N.W., Washington, D.C. Seating is limited; reporters who wish to attend should contact the Office of News and Public Information; 202-334-2138 or email@example.com. Those who cannot attend can watch a live webcast of the event. For more information, including a complete agenda, or to register to view the live webcast, visit http://www.iom.edu/Activities/Research/QualityUnregulatedStemCellTherapies/2013-NOV-18.aspx.